The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer-Reference-Cited by-同舟云学术

The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer

Published:2023-07 Issue:21 Volume:19 Page:1451-1459
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Kourie Hampig Raphael¹,Mahrous Mervat²³,Naim Nabih¹^ORCID,Zouein Joseph¹^ORCID,Benbrahim Zineb⁴,Rasul Kakil⁵,Mokhtar Mohsen⁶,Shehri Ahmad Al⁷,Shakeeb Mahmoud⁸,Khatib Sami⁹,Al-Shamsi Humaid¹⁰,Shamseddine Ali¹¹^ORCID,Smyth Elisabeth¹²

Affiliation:

1. Hematology-Oncology Department, Saint Joseph University of Beirut, Lebanon

2. Prince Sultan Military Medical City, Riyadh, KSA

3. Oncology Department, Minia University, Minia, Egypt

4. CHU Hassan II, Morocco

5. Natonal Center for Cancer Care & Research in Hamad Medical Corporation, Doha, Qatar

6. Director of Kasr Al Aini Oncology Unit, Cairo University, Egypt

7. King Abdullah Medical City, Jeddah, KSA

8. Medical City Complex, Baghdad, Iraq

9. Secretary General of the Arab Medical Association Against Cancer, Jordan

10. President of the Emirates Oncology Society, Burjeel Cancer Institute & VPS Healthcare, UAE

11. Director of Gastrointestinal/Genitourinary Cancer Program at the Hematology-Oncology Division Basile Cancer Institute, American University of Beirut, Lebanon

12. Cambridge University Hospital, NHS Foundation Trust, Cambridge, UK

Abstract

Gastric cancer (GC) ranks as the fifth most prevalent cancer and the fourth deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, GC represents about 4.8% of cancer cases with more than 35,000 new cases in 2020. To strengthen and improve the management of this cancer in the region, a group of MENA experts in the field of GC developed the first MENA consensus recommendations for the management of advanced GC. A total of 28 statements were drafted, discussed and voted on, using a modified Delphi process, during a virtual consensus meeting. The statements addressed the areas of epidemiology, biomarkers and treatment.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon-2023-0219

Reference41 articles.

1. WHO GLOBOCAN. Cancer today http://gco.iarc.fr/today/home (Accessed 18 January 2023).

2. The Epidemiology of Gastric Cancers in the Era of Helicobacter pylori Eradication: A Nationwide Cancer Registry-Based Study in Taiwan

3. Gastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Survival outcomes of management in metastatic gastric adenocarcinoma patients

5. The Prognostic Determinants of Gastric Cancer Treatment Outcome in Omani Arab Patients